Orexo AB - Company & Market Research Reports

Orexo AB is a specialty pharmaceutical company in the United States. Its launched products include Zubsolv sublingual tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, an active substance zolpidem that is used for the treatment of short-term insomnia. It has collaboration agreement with Mundipharma for the development and commercialization of Zubsolv and with AstraZeneca with regards to the OX-Cysteinyl Leukotriene Inhibitor project. Founded in 1995, the company is headquartered in Uppsala, Sweden.

From
From
From
From
From
From
From
From
Drug Overdose - Pipeline Review, H2 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H2 2018

  • Drug Pipelines
  • 65 Pages
From
From
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
From
From
From
From
Loading Indicator
adroll